GI
DAWN

GAMMA Investing’s Day One Biopharmaceuticals DAWN Stock Holding History

GAMMA Investing’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-586
Closed -$12.6K – 4165
2026
Q1 		$12.6K Buy
586
+483
+469% +$6.81K ﹤0.01% 2954
2025
Q4 		$960 Buy
103
+64
+164% +$535 ﹤0.01% 3799
2025
Q3 		$275 Sell
39
-8
-17% -$55 ﹤0.01% 3777
2025
Q2 		$306 Sell
47
-236
-83% -$1.62K ﹤0.01% 3692
2025
Q1 		$2.24K Buy
283
+264
+1,389% +$2.84K ﹤0.01% 3382
2024
Q4 		$241 Sell
19
-49
-72% -$682 ﹤0.01% 3689
2024
Q3 		$947 Buy
68
+26
+62% +$371 ﹤0.01% 3271
2024
Q2 		$579 Sell
42
-117
-74% -$1.71K ﹤0.01% 3183
2024
Q1 		$2.63K Buy
159
+122
+330% +$1.83K ﹤0.01% 2664
2023
Q4 		$557 Buy
+37
New +$449 ﹤0.01% 2940

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's DAWN Position: Q2 2026 in Review

GAMMA Investing sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 586 shares — an estimated $12.6K sold.

GAMMA Investing first reported a position in DAWN in Q4 2023 and held it in 10 quarters. The position peaked at $12.6K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • GAMMA Investing reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • GAMMA Investing sold 586 Day One Biopharmaceuticals shares in Q2 2026, an estimated $12.6K.
  • GAMMA Investing first reported a position in Day One Biopharmaceuticals in Q4 2023 and held it in 10 quarters.
  • GAMMA Investing's Day One Biopharmaceuticals position peaked at $12.6K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.